These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38367938)

  • 1. The individualized delineation of clinical target volume for primary nasopharyngeal carcinoma based on invasion risk of substructures: A prospective, real-world study with a large population.
    Wang X; Huang N; Yip PL; Wang J; Huang R; Sun Z; Kang D; He Q; Deng X; Zhao C; Chua MLK; Han F
    Radiother Oncol; 2024 May; 194():110154. PubMed ID: 38367938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and toxicity of individualized intensity-modulated radiotherapy based on the tumor extension patterns of nasopharyngeal carcinoma.
    Lin L; Yao JJ; Zhou GQ; Guo R; Zhang F; Zhang Y; Xu L; Zhang LL; Lin AH; Ma J; Sun Y
    Oncotarget; 2016 Apr; 7(15):20680-90. PubMed ID: 26980744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualization of Clinical Target Volume Delineation Based on Stepwise Spread of Nasopharyngeal Carcinoma: Outcome of More Than a Decade of Clinical Experience.
    Sanford NN; Lau J; Lam MB; Juliano AF; Adams JA; Goldberg SI; Lu HM; Lu YC; Liebsch NJ; Curtin HD; Chan AW
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):654-668. PubMed ID: 30712708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the patterns and pathways of local recurrence of nasopharyngeal carcinoma: evidence for individualized clinical target volume delineation.
    Ou X; Yan W; Huang Y; He X; Ying H; Lu X; Zhu H; Wu B; Wang J; Hu C
    Radiat Oncol; 2023 Mar; 18(1):55. PubMed ID: 36944958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized clinical target volume delineation and efficacy analysis in unilateral nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT): 10-year summary.
    Xie DH; Wu Z; Li WZ; Cheng WQ; Tao YL; Wang L; Lv SW; Lin FF; Cui NJ; Zhao C; Ma J; Huang SM; Lu TX; Han YQ; Su Y
    J Cancer Res Clin Oncol; 2022 Aug; 148(8):1931-1942. PubMed ID: 35486182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10-Year Results of a Phase 2 Study.
    Zhao C; Miao JJ; Hua YJ; Wang L; Han F; Lu LX; Xiao WW; Wu HJ; Zhu MY; Huang SM; Lin CG; Deng XW; Xie CH
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):836-844. PubMed ID: 30954521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
    Zheng Y; Han F; Xiao W; Xiang Y; Lu L; Deng X; Cui N; Zhao C
    Radiat Oncol; 2015 Jan; 10():17. PubMed ID: 25582731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Han L; Lin SJ; Pan JJ; Chen CB; Zhang Y; Zhang XC; Liao XY; Chen QS
    Chin J Cancer; 2010 Feb; 29(2):145-50. PubMed ID: 20109341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure patterns and individualized treatment plans of reirradiation for inoperable locally recurrent nasopharyngeal carcinoma.
    Lin C; Lu Q; Chen Y; Chen X; Huang Y; Zhong H; Peng X; Hu C; Chen B; Lin S; Zong J
    Sci Rep; 2024 Aug; 14(1):17887. PubMed ID: 39095403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective 10-Year Observational Study of Reduction of Radiation Therapy Clinical Target Volume and Dose in Early-Stage Nasopharyngeal Carcinoma.
    Miao J; Di M; Chen B; Wang L; Cao Y; Xiao W; Wong KH; Huang L; Zhu M; Huang H; Huang S; Han F; Deng X; Xiang Y; Lv X; Xia W; Tan SH; Wee JTS; Guo X; Chua MLK; Zhao C
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):672-682. PubMed ID: 32272183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified reduced-volume intensity-modulated radiation therapy in non-metastatic nasopharyngeal carcinoma: A prospective observation series.
    Guo Q; Zheng Y; Lin J; Xu Y; Hu C; Zong J; Lu T; Xu H; Chen B; Liang Q; Xiao Y; Pan J; Lin S
    Radiother Oncol; 2021 Mar; 156():251-257. PubMed ID: 33418007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
    Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
    Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
    Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
    Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
    Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study.
    Liu F; Luo T; Jin T; Zhang J; Xiang Z; Yan R; Xie L; Wu X; Zhang H; Wang F; Li P; Liu L
    BMC Cancer; 2019 Jun; 19(1):554. PubMed ID: 31176358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma.
    Tao CJ; Liu X; Tang LL; Mao YP; Chen L; Li WF; Yu XL; Liu LZ; Zhang R; Lin AH; Ma J; Sun Y
    Chin J Cancer; 2013 Oct; 32(10):525-32. PubMed ID: 24016394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: long-term outcome of a multicenter prospective study.
    Wang R; Wu F; Lu H; Wei B; Feng G; Li G; Liu M; Yan H; Zhu J; Zhang Y; Hu K
    J Cancer Res Clin Oncol; 2013 Jan; 139(1):139-45. PubMed ID: 22986812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.